1-9 of 9
lymphoma, t-cell, peripheral
Close
Sort by
Journal Articles

Enhancing antitumor immunity through checkpoint blockade as a therapeutic strategy in T-cell lymphomas

Alexander Neuwelt, Taha Al-Juhaishi, Eduardo Davila, Bradley Haverkos
Journal: Blood Advances
Blood Adv (2020) 4 (17): 4256–4266.
https://doi.org/10.1182/bloodadvances.2020001966
Published: 2020
Journal Articles

Multiple mutations at exon 2 of RHOA detected in plasma from patients with peripheral T-cell lymphoma

Barbara Ottolini, Nadia Nawaz, Christopher S. Trethewey, Sami Mamand, Rebecca L. Allchin, Richard Dillon, Paul A. Fields, Matthew J. Ahearne, Simon D. Wagner
Journal: Blood Advances
Blood Adv (2020) 4 (11): 2392–2403.
https://doi.org/10.1182/bloodadvances.2019001075
Published: 2020
Includes: Supplemental data
Journal Articles

Interleukin-2–inducible T-cell kinase inhibitors modify functional polarization of human peripheral T-cell lymphoma cells

Sami Mamand, Matthew Carr, Rebecca L. Allchin, Matthew J. Ahearne, Simon D. Wagner
Journal: Blood Advances
Blood Adv (2019) 3 (5): 705–710.
https://doi.org/10.1182/bloodadvances.2018027821
Published: 2019
Includes: Supplemental data
Journal Articles

Baseline and interim functional imaging with PET effectively risk stratifies patients with peripheral T-cell lymphoma

Clinical Trials & Observations
Neha Mehta-Shah, Kimiteru Ito, Kurt Bantilan, Alison J. Moskowitz, Craig Sauter, Steven M. Horwitz, Heiko Schöder
Journal: Blood Advances
Blood Adv (2019) 3 (2): 187–197.
https://doi.org/10.1182/bloodadvances.2018024075
Published: 2019
Includes: Supplemental data
Journal Articles

CapTCR-seq: hybrid capture for T-cell receptor repertoire profiling

David T. Mulder, Etienne R. Mahé, Mark Dowar, Youstina Hanna, Tiantian Li, Linh T. Nguyen, Marcus O. Butler, Naoto Hirano, Jan Delabie, Pamela S. Ohashi, Trevor J. Pugh
Journal: Blood Advances
Blood Adv (2018) 2 (23): 3506–3514.
https://doi.org/10.1182/bloodadvances.2017014639
Published: 2018
Includes: Supplemental data
Journal Articles

Proteomic profiling identifies outcome-predictive markers in patients with peripheral T-cell lymphoma, not otherwise specified

Clinical Trials & Observations
Maja Ludvigsen, Martin Bjerregård Pedersen, Kristina Lystlund Lauridsen, Tim Svenstrup Poulsen, Stephen Jacques Hamilton-Dutoit, Søren Besenbacher, Knud Bendix, Michael Boe Møller, Peter Nørgaard, Francesco d’Amore, Bent Honoré
Journal: Blood Advances
Blood Adv (2018) 2 (19): 2533–2542.
https://doi.org/10.1182/bloodadvances.2018019893
Published: 2018
Includes: Supplemental data
Journal Articles

Microenvironmental immune cell signatures dictate clinical outcomes for PTCL-NOS

Takeshi Sugio, Kohta Miyawaki, Koji Kato, Kensuke Sasaki, Kyohei Yamada, Javeed Iqbal, Toshihiro Miyamoto, Koichi Ohshima, Takahiro Maeda, Hiroaki Miyoshi, Koichi Akashi
Journal: Blood Advances
Blood Adv (2018) 2 (17): 2242–2252.
https://doi.org/10.1182/bloodadvances.2018018754
Published: 2018
Includes: Supplemental data
Journal Articles

Pilot trial of ibrutinib in patients with relapsed or refractory T-cell lymphoma

Clinical Trials & Observations
Anita Kumar, Santosha Vardhana, Alison J. Moskowitz, Pierluigi Porcu, Ahmet Dogan, Jason A. Dubovsky, Matthew J. Matasar, Zhigang Zhang, Anas Younes, Steven M. Horwitz
Journal: Blood Advances
Blood Adv (2018) 2 (8): 871–876.
https://doi.org/10.1182/bloodadvances.2017011916
Published: 2018
Includes: Supplemental data
Journal Articles

Redefining the role of etoposide in first-line treatment of peripheral T-cell lymphoma

Clinical Trials & Observations
Young Ae Kim, Ja Min Byun, Keeho Park, Gi Hwan Bae, Dukhyoung Lee, Dong Sook Kim, Sung-Soo Yoon, Youngil Koh
Journal: Blood Advances
Blood Adv (2017) 1 (24): 2138–2146.
https://doi.org/10.1182/bloodadvances.2017010819
Published: 2017
Includes: Supplemental data